Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Esketamine Nasal Spray versus Quetiapine for Resistant Depression

Open access
Mark Abie Horowitz, Martin Plöderl, Florian Naudet · 2024 · New England Journal of Medicine

Abstract

To the Editor: In their article on the ESCAPE-TRD trial, Reif et al. (Oct. 5 issue) 1 report on the efficacy and safety of esketamine nasal spray in comparison with extended-release quetiapine therapy in patients with treatment-resistant depression. The between-group differences in the change from baseline in the score on the Montgomery–Åsberg Depression Rating Scale (MADRS; scores range from 0 to 60, with higher scores indicating more severe depression) at 8 weeks (−2.8 points, favoring esketamine) and 32 weeks (−2.2 points, also favoring esketamine) were significant but were less than the minimum clinically important difference. 2 The data on remission that were . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc2313230

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Research works printed but not linked: 1

  1. 10.1136/bmjebm-2020-111600 · DOI · Paper page

Cited by

See all 1

Metadata

Authors
Horowitz, M. A., Plöderl, M., & Naudet, F.
Affiliations
  • Royal Marsden NHS Foundation Trust (GB)
  • Paracelsus Medical University (AT)
  • CIC Rennes (FR)
Venue
New England Journal of Medicine
Published
2024-01-04
Volume
390
Issue
1
Pages
93-95
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4390547870
Cited by
1
References
13
Citations by year
2025: 1
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords
esketamine, nasal spray, quetiapine, treatment-resistant depression, antidepressant efficacy, remission, minimal clinically important difference, Montgomery-Asberg Depression Rating Scale
MeSH terms
Quetiapine Fumarate, Antidepressive Agents, Depression, Humans, Ketamine, Nasal Sprays

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Esketamine Nasal Spray versus Quetiapine for Resistant Depression. https://app.cochat.ai/papers/10.1056/nejmc2313230
The paper
Horowitz, M. A., Plöderl, M., & Naudet, F. (2024). Esketamine Nasal Spray versus Quetiapine for Resistant Depression. New England Journal of Medicine. https://doi.org/10.1056/nejmc2313230

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.